VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Return
24.65%
This Quarter Return
+8.26%
1 Year Return
+24.65%
3 Year Return
+82.72%
5 Year Return
+113.39%
10 Year Return
–
AUM
$2.55B
AUM Growth
+$25.8M
(+1%)
Cap. Flow
-$166M
Cap. Flow
% of AUM
-6.49%
Top 10 Holdings %
Top 10 Hldgs %
14.48%
Holding
1,057
New
159
Increased
342
Reduced
417
Closed
139
Top Buys
| 1 |
Illumina
ILMN
|
+$21.7M |
| 2 |
Aptiv
APTV
|
+$19.9M |
| 3 |
NVIDIA
NVDA
|
+$12.1M |
| 4 |
IPG Photonics
IPGP
|
+$10.3M |
| 5 |
FSD
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
|
+$5.73M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$37.7M |
| 2 |
iRobot
IRBT
|
+$24.8M |
| 3 |
AeroVironment
AVAV
|
+$24.8M |
| 4 |
3D Systems Corporation
DDD
|
+$10.4M |
| 5 |
Azenta
AZTA
|
+$10M |
Sector Composition
| 1 | Technology | 27.48% |
| 2 | Industrials | 12.72% |
| 3 | Healthcare | 12.25% |
| 4 | Consumer Discretionary | 9.24% |
| 5 | Financials | 5.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
301
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.24M | 0.09% |
47,581
-3,431
| -7% | -$162K |
|
302
MacroGenics
MGNX
$109M
| $2.24M | 0.09% |
104,486
-6,963
| -6% | -$149K |
|
303
Xencor
XNCR
$593M
| $2.24M | 0.09% |
57,438
-3,828
| -6% | -$149K |
|
304
Zymeworks
ZYME
$1.15B
| $2.23M | 0.09% |
142,306
-9,485
| -6% | -$149K |
|
305
Archrock
AROC
$4.22B
| $2.21M | 0.09% |
+181,320
| New | +$2.21M |
|
|
MANT
306
DELISTED
Mantech International Corp
MANT
| $2.19M | 0.09% |
34,652
-15,941
| -32% | -$1.01M |
|
|
MOR
307
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $2.19M | 0.09% |
81,901
-5,872
| -7% | -$157K |
|
308
Nuveen Real Asset Income & Growth Fund
JRI
$378M
| $2.18M | 0.09% |
135,483
+5,535
| +4% | +$89.2K |
|
|
KEM
309
DELISTED
KEMET Corporation
KEM
| $2.16M | 0.08% |
116,578
-62,889
| -35% | -$1.17M |
|
310
Terreno Realty
TRNO
$5.96B
| $2.15M | 0.08% |
57,042
+10,041
| +21% | +$378K |
|
|
UNT
311
DELISTED
UNIT Corporation
UNT
| $2.15M | 0.08% |
82,495
-38,342
| -32% | -$999K |
|
312
Atara Biotherapeutics
ATRA
$83.9M
| $2.13M | 0.08% |
2,060
-137
| -6% | -$142K |
|
|
CLLS
313
Cellectis
CLLS
$286M
| $2.13M | 0.08% |
75,496
-5,031
| -6% | -$142K |
|
|
TWTR
314
DELISTED
Twitter, Inc.
TWTR
| $2.13M | 0.08% |
74,680
-5,190
| -6% | -$148K |
|
|
HA
315
DELISTED
Hawaiian Holdings, Inc.
HA
| $2.11M | 0.08% |
52,680
-9,202
| -15% | -$369K |
|
316
Apogee Enterprises
APOG
$895M
| $2.11M | 0.08% |
+50,964
| New | +$2.11M |
|
317
Skywest
SKYW
$4.35B
| $2.1M | 0.08% |
35,616
-30,193
| -46% | -$1.78M |
|
|
GCI
318
DELISTED
Gannett Co., Inc
GCI
| $2.09M | 0.08% |
208,346
-31,136
| -13% | -$312K |
|
319
Artisan Partners
APAM
$3.28B
| $2.08M | 0.08% |
64,324
-43,384
| -40% | -$1.41M |
|
320
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$1.86B
| $2.05M | 0.08% |
83,660
+3,420
| +4% | +$83.8K |
|
321
Newmont
NEM
$83.4B
| $2.04M | 0.08% |
67,609
-32,675
| -33% | -$987K |
|
322
Arcus Biosciences
RCUS
$1.2B
| $2.04M | 0.08% |
146,384
-9,755
| -6% | -$136K |
|
323
Watsco
WSO
$16.3B
| $2.04M | 0.08% |
11,447
-3,884
| -25% | -$692K |
|
324
Criteo
CRTO
$1.21B
| $2.04M | 0.08% |
+88,817
| New | +$2.04M |
|
|
CY
325
DELISTED
Cypress Semiconductor
CY
| $2.04M | 0.08% |
+140,461
| New | +$2.04M |
|